OCT Angiography in Vitreo and Chorioretinal Pathologies

Optical Coherence Tomography Angiography in Vitreo and Chorioretinal Pathologies Under the Influence of Dark and Light Adaptation

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT03390205

Enrollment

100

Registered

2018-01-04

Start date

2018-02-28

Completion date

2019-03-31

Last updated

2018-01-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Optical Coherence Tomography

Brief summary

In many diseases of the vitreo and chorioretinal complex, perfusion changes have a diagnostic, prognostic or causative role. The visualisation of perfusion was limited to invasive techniques, which were only to depict vasculature in one plane. Optical coherence tomography is able to visualise and quantify eye perfusion layer-specific and non-invasive.

Interventions

DIAGNOSTIC_TESTOptical coherence tomography angiography under dark and light adaptation

Optical coherence tomography angiography under dark and light adaptation with pupil dilatation

Study design

Observational model

CASE_CONTROL

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to 85 Years

Inclusion criteria

* Patient with vitreo and chorioretinal pathology, aged-adapted controls

Exclusion criteria

* Minors, concomitant ocular pathologies, pregnancy, contra-indication for tropicamide

Design outcomes

Primary

Measure	Time frame	Description
Vessel density	5 minutes after intervention ends	Vessel density measurements of macula and optic nerve

Contacts

Primary ContactPieter Jan Nelis, MD

nelispieter@gmail.com0032494354198

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026